Market research
BAX Baxter International Inc
NYSE USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 14B
- P/E ratio
- Not available
- Analyst target
- 28.7273
- Dividend yield
- 0.8%
- Beta
- 0.59
Profile
Company facts
- Exchange
- NYSE
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- US0718131099
- Market cap
- 14B
- P/E ratio
- Not available
- Analyst target
- 28.7273
- Dividend yield
- 0.8%
- Beta
- 0.59
About
About Baxter International Inc
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the BAX discussion.
5 years, 4 months ago
Baxter International Inc is currently in a long term uptrend where the price is trading 0.7% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Baxter International Inc's total revenue rose by 4.7% to $3B since the same quarter in the previous year.
Its net income has increased by 830.4% to $168M since the same quarter in the previous year.
Finally, its free cash flow fell by 25.5% to $475M since the same quarter in the previous year.
Based on the above factors, Baxter International Inc gets an overall score of 4/5.